KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Restructuring Costs (2016 - 2025)

Teladoc Health (TDOC) has disclosed Restructuring Costs for 11 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs fell 37.03% to $12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.8 million through Dec 2025, down 7.71% year-over-year, with the annual reading at $18.8 million for FY2025, 7.71% down from the prior year.
  • Restructuring Costs hit $12.0 million in Q4 2025 for Teladoc Health, up from $1.9 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $19.1 million in Q4 2024 to a low of -$1.6 million in Q4 2022.
  • Historically, Restructuring Costs has averaged $4.5 million across 5 years, with a median of $3.6 million in 2021.
  • Biggest five-year swings in Restructuring Costs: plummeted 134.59% in 2022 and later soared 20185.11% in 2024.
  • Year by year, Restructuring Costs stood at $4.6 million in 2021, then tumbled by 134.59% to -$1.6 million in 2022, then surged by 105.96% to $94000.0 in 2023, then skyrocketed by 20185.11% to $19.1 million in 2024, then plummeted by 37.03% to $12.0 million in 2025.
  • Business Quant data shows Restructuring Costs for TDOC at $12.0 million in Q4 2025, $1.9 million in Q3 2025, and $2.7 million in Q2 2025.